“…Moreover, pharmaceutical research, manufacture, and regulation are enhancing the development of solid active ingredients, delivered as powders or tablets; however, many solid drugs which perform well in in vitro evaluation remain too insoluble for the body to absorb [ 8 , 9 ]. Most of the bioactive agents sold for pharmaceutical or food industries are salts [ 10 , 11 ], and in this context, ionic liquids (ILs) represent a promising class of drug candidates whose physicochemical and pharmaceutical properties can be easily tuned [ 12 , 13 , 14 , 15 , 16 , 17 ]. In this regard, the imidazolium skeleton can be transformed into ionic liquids with promisingly potent pharmacological properties [ 18 , 19 , 20 , 21 ].…”